# Selenium to Improve Neurological Outcome After Cardiac Arrest

> **NCT01390506** · PHASE2 · WITHDRAWN · sponsor: **Medical University of Graz**

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** Sodium-selenite
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01390506
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2018-07
- **Final completion:** 2019-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The company did not provide the study product
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390506, "Selenium to Improve Neurological Outcome After Cardiac Arrest". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01390506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*